{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (1S,10R,11S,13R,14R,15S)-5-(cyclopentyloxy)-14-ethynyl-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-triene-13,14-diol
| image = Nilestriol.svg
| width =

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 39791-20-3
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 38346
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 35146
| UNII = 7JA3B3IALU
| ChEMBL = 2104468
| KEGG = D05212

<!--Chemical data-->
| C=25 | H=32 | O=3
| molecular_weight = 380.51978 g/mol
| smiles = C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@]2(C#C)O)O)CCC4=C3C=CC(=C4)OC5CCCC5
| StdInChI = 1S/C25H32O3/c1-3-25(27)23(26)15-22-21-10-8-16-14-18(28-17-6-4-5-7-17)9-11-19(16)20(21)12-13-24(22,25)2/h1,9,11,14,17,20-23,26-27H,4-8,10,12-13,15H2,2H3/t20-,21-,22+,23-,24+,25+/m1/s1
| StdInChIKey = CHZJRGNDJLJLAW-RIQJQHKOSA-N
| synonyms = 
}}

'''Nilestriol''' ([[International Nonproprietary Name|INN]]) (brand name '''Wei Ni An'''; developmental code name '''LY-49825'''), also known as '''nylestriol''' ([[United States Adopted Name|USAN]], [[British Approved Name|BAN]]), is a [[Organic compound#Synthetic compounds|synthetic]], [[steroid]]al [[estrogen]] that was patented in 1971<ref>{{cite book|title=Official Gazette of the United States Patent and Trademark Office: Patents|url=https://books.google.com/books?id=vLk5AQAAMAAJ|year=1975|publisher=U.S. Department of Commerce, Patent and Trademark Office|page=1677}}</ref> and is marketed in [[China]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA891|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=891–}}</ref><ref name="Drugs.com">https://www.drugs.com/international/nilestriol.html</ref> It is the [[cyclopentane|3-cyclopentyl]] [[ether]] of [[ethinylestriol]], and is also known as '''ethinylestriol cyclopentyl ether''' ('''EE3CPE''').<ref name="McGuire2013">{{cite book|author=William McGuire|title=Experimental Biology|url=https://books.google.com/books?id=q9HkBwAAQBAJ&pg=PA161|date=14 December 2013|publisher=Springer Science & Business Media|isbn=978-1-4757-4673-0|pages=161–}}</ref> Nilestriol is a [[prodrug]] of ethinylestriol, and is a more [[potency (pharmacology)|potent]] estrogen in comparison.<ref name="McGuire2013" /> It is described as a slowly-[[metabolism|metabolized]], long-acting estrogen and derivative of [[estriol]].<ref name="Schoenberg1977">{{cite book|author=Daniel Robert Schoenberg|title=Biochemical Properties of the Cytoplasmic Estrogen Receptors from Immature Rat and Mature Rabbit Uteri|url=https://books.google.com/books?id=oXrTAAAAMAAJ|year=1977|publisher=University of Wisconsin|page=A-17}}</ref><ref name="ExcerptaMedica1978">{{cite book|title=Excerpta medica. Section 10: Obstetrics and gynecology|url=https://books.google.com/books?id=55-aAAAAIAAJ|year=1978}}</ref> Nilestriol was assessed in combination with [[levonorgestrel]] for the potential treatment of [[menopause|postmenopausal]] [[osteoporosis]], but this formulation ultimately was not marketed.<ref name="Aronson2009">{{cite book|author=Jeffrey K. Aronson|title=Meyler's Side Effects of Endocrine and Metabolic Drugs|url=https://books.google.com/books?id=BWMeSwVwfTkC&pg=PA173|date=21 February 2009|publisher=Elsevier|isbn=978-0-08-093292-7|pages=173–}}</ref>

==See also==
* [[Ethinylestradiol]]
* [[Mestranol]]
* [[Quinestradol]]
* [[Quinestrol]]

==References==
{{reflist|30em}}

{{Estrogens and antiestrogens}}
{{Estrogen receptor modulators}}

[[Category:Diols]]
[[Category:Estranes]]
[[Category:Prodrugs]]
[[Category:Synthetic estrogens]]
[[Category:Cyclopentanes]]


{{genito-urinary-drug-stub}}
{{steroid-stub}}